Eurasian mining, markets, policy and technology intelligenceCategory
280 published stories in this archive.
Industry News
Uzbekistan inaugurates its first casting and rolling complex at Uzmetkombinat, boosting hot-rolled sheet metal production to 1 million tons annually and creating 1,200 jobs.
Policies and Regulation
Kazakh PM Olzhas Bektenov orders new stimulus measures for metallurgy, including full utilization of non-ferrous plants and Qarmet modernization, to boost investment and industrial growth.
Policies and Regulation
The EU is forming an emergency task force to prepare for potential rare earths supply disruptions from China, as current export arrangements expire in October, threatening critical manufacturing inputs.
Policies and Regulation
European Aluminium is urging the EU to close a sanctions loophole allowing Russian primary aluminium to enter the bloc via third-country processing — with Turkey identified as the main conduit — calling…
Policies and Regulation
The US House has passed the bipartisan DOMINANCE Act to strengthen allied cooperation on critical minerals and reduce dependence on China, which controls approximately 90% of global rare earth processing capacity, as…
Policies and Regulation
Carmarthenshire Council has refused the last live opencast coal mining application in the UK, rejecting Bryn Bach Coal's Glan Lash extension on environmental grounds and leaving no active coal mine applications anywhere…
Policies and Regulation
Kazakh exporters of aluminum and steel products may face more than €100 million in annual costs under the EU’s new CBAM carbon regulation system.
Partner Podcasts
Do we really need 293 new (critical mineral) mines for the energy transition – or just a new mindset? Will some of those copper, lithium, graphite, rare-earth… mines be built in the…
Policies and Regulation
A new report accuses the EU of weakening environmental safeguards to fast-track industrial and energy projects across Europe.
Policies and Regulation
The EU has agreed the Critical Medicines Act, requiring member states to diversify pharmaceutical supply chains, expand domestic production and coordinate emergency stockpiles to reduce dangerous dependence on single-source suppliers.